PFE · XBRL financial data

Pfizer financial statements, every fiscal year

The same tables from 7 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (PFE's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue	41,651	81,288	100,330	58,496	63,627	62,579
Revenue from contracts with customers	41,908	81,288	91,793	50,914	—	—
Cost of goods and services sold	8,692	30,821	34,344	24,954	17,851	16,067
Selling, general and administrative	11,615	12,703	13,677	14,771	14,730	13,794
Interest income	73	36	251	1,624	545	603
Interest expense	1,449	1,291	1,238	2,209	3,091	2,671
Other income (expense)	(669)	4,878	(217)	835	(4,388)	(6,724)
Income tax expense (benefit)	477	1,852	3,328	(1,115)	(28)	(266)
Net income (loss)	9,616	21,979	31,372	2,119	8,031	7,771
Earnings per share, basic USD per share	1.73	3.92	5.59	0.38	1.42	1.37
Earnings per share, diluted USD per share	1.71	3.85	5.47	0.37	1.41	1.36
Weighted average shares, basic millions of shares	5,555	5,601	5,608	5,643	5,664	5,683
Weighted average shares, diluted millions of shares	5,632	5,708	5,733	5,709	5,700	5,713

Fiscal years (PFE's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	1,784	1,944	416	2,853	1,043	1,142
Short-term investments	10,437	—	—	—	—	—
Marketable securities	9,709	22,014	18,743	4,400	10,881	9,183
Marketable securities, non-current	128	521	352	150	0	1
Accounts receivable	7,930	11,479	10,952	11,177	11,463	11,874
Inventory	8,046	9,059	8,981	10,189	10,851	10,654
Total current assets	35,067	59,693	51,259	43,333	50,358	42,898
Property and equipment, net	13,900	14,882	16,274	18,940	18,393	19,317
Right-of-use asset	1,393	2,839	3,002	2,924	2,289	2,213
Goodwill	49,577	49,208	51,375	67,783	68,527	71,264
Total assets	154,229	181,476	197,205	226,501	213,396	208,160
Accounts payable	4,309	5,578	6,809	6,710	5,633	5,240
Commercial paper	556	0	0	7,965	2,453	0
Current portion of long-term debt	2,002	1,636	2,560	2,254	3,747	2,997
Total current liabilities	25,920	42,671	42,138	47,794	42,995	36,984
Long-term debt	37,133	36,195	32,884	61,538	57,405	61,641
Lease liability, non-current	1,114	2,510	2,597	2,626	2,286	2,291
Total liabilities	90,756	104,013	101,288	137,213	124,899	121,385
Retained earnings	96,770	103,394	125,656	118,353	116,725	114,610
Total stockholders' equity	63,238	77,201	95,661	89,014	88,203	86,476
Total liabilities and equity	154,229	181,476	197,205	226,501	213,396	208,160
Common shares outstanding (cover page) millions of shares	5,578	5,623	5,619	5,647	5,667	5,686

Fiscal years (PFE's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	9,616	21,979	31,372	2,119	8,031	7,771
Stock-based compensation	756	1,182	872	525	877	799
Depreciation and amortization	4,681	5,191	5,064	6,290	7,013	6,592
Net cash from operating activities	14,403	32,580	29,267	8,700	12,744	11,704
Purchases of property and equipment	2,252	2,711	3,236	3,907	2,909	2,629
Net cash from investing activities	(4,271)	(22,546)	(15,783)	(32,278)	2,652	(1,351)
Share repurchases	0	0	2,000	0	0	—
Proceeds from long-term debt	5,222	997	0	30,831	0	9,678
Repayments of long-term debt	4,003	2,004	3,298	2,569	2,250	6,757
Net cash from financing activities	(9,649)	(9,816)	(14,834)	26,066	(17,140)	(10,304)
Net change in cash	475	159	(1,515)	2,448	(1,810)	91

The peer list for this company is being put together from its industry's latest filings. Reload the page in a minute to see it.

Not investment advice. Not affiliated with the U.S. SEC.